Works matching IS 10073639 AND DT 2024 AND VI 34 AND IP 7

Results: 10

乳腺癌中线粒体功能障碍与CPT1A/ERK信号转导通路共同调节乳腺癌恶性行为的机制研究.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 650, doi. 10.19401/j.cnki.1007-3639.2024.07.004

By:

姜丹;
宋国庆;
王晓丹

Publication type:

Article

靶向CD99的CAR-T细胞扩增优化研究.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 639, doi. 10.19401/j.cnki.1007-3639.2024.07.003

By:

王伊玄;
于淼;
赵家旋;
赵芬芳;
曾毅;
王友湧;
祝海川;
张同存;
史江舟

Publication type:

Article

激素敏感性前列腺癌患者中 PSMA PET/CT 衍生参数与循环肿瘤DNA特征之间的相关性分析.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 680, doi. 10.19401/j.cnki.1007-3639.2024.07.007

By:

潘剑;
叶定伟;
朱耀;
王备合

Publication type:

Article

<sup>177</sup>Lu-PSMA 放射性配体疗法治疗前列腺癌的临床实践专家共识 (2024 年版).

Published in:: China Oncology, 2024, v. 34, n. 7, p. 702, doi. 10.19401/j.cnki.1007-3639.2024.07.010
Publication type:: Article

鞘内注射治疗实体瘤脑膜转移的临床研究进展.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 695, doi. 10.19401/j.cnki.1007-3639.2024.07.009

By:

黄思捷;
康勋;
李文斌

Publication type:

Article

关于女性乳腺癌患者绝经状态判断两个关键问题的临床思考.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 619, doi. 10.19401/j.cnki.1007-3639.2024.07.001

By:

张剑

Publication type:

Article

溶瘤病毒联合免疫治疗在恶性肿瘤治疗中的应用进展.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 686, doi. 10.19401/j.cnki.1007-3639.2024.07.008

By:

梁滢昀;
陈健华

Publication type:

Article

局部晚期食管鳞状细胞癌患者新辅助免疫治疗联合化疗后行根治性手术的术后病理学缓解程度及影响因素分析.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 669, doi. 10.19401/j.cnki.1007-3639.2024.07.006

By:

廖梓伊;
彭杨;
曾蓓蕾;
马影颖;
曾丽;
甘科论;
马代远

Publication type:

Article

派安普利单抗联合安罗替尼和化疗围手术期治疗局部进展期胃癌的探索性研究.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 659, doi. 10.19401/j.cnki.1007-3639.2024.07.005

By:

刘帅;
张凯;
张晓青;
栾巍

Publication type:

Article

普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究.

Published in:

China Oncology, 2024, v. 34, n. 7, p. 628, doi. 10.19401/j.cnki.1007-3639.2024.07.002

By:

王蔓莉;
陈辉;
段智;
许奇美;
李贞

Publication type:

Article